DrugPatentWatch Database Preview
EFINACONAZOLE - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for efinaconazole and what is the scope of patent protection?
Efinaconazole
is the generic ingredient in one branded drug marketed by Bausch and is included in one NDA. There are twelve patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.Efinaconazole has sixty-six patent family members in twenty-three countries.
There are fourteen drug master file entries for efinaconazole.
Summary for EFINACONAZOLE
International Patents: | 66 |
US Patents: | 12 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 14 |
Bulk Api Vendors: | 45 |
Clinical Trials: | 5 |
Patent Applications: | 258 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for EFINACONAZOLE |
DailyMed Link: | EFINACONAZOLE at DailyMed |
Recent Clinical Trials for EFINACONAZOLE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Dong-A ST Co., Ltd. | Phase 4 |
Western University of Health Sciences | Phase 3 |
Valeant Pharmaceuticals International, Inc. | Phase 4 |
Paragraph IV (Patent) Challenges for EFINACONAZOLE
Tradename | Dosage | Ingredient | NDA | Submissiondate |
---|---|---|---|---|
JUBLIA | SOLUTION;TOPICAL | efinaconazole | 203567 | 2018-06-06 |
US Patents and Regulatory Information for EFINACONAZOLE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | JUBLIA | efinaconazole | SOLUTION;TOPICAL | 203567-001 | Jun 6, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
Bausch | JUBLIA | efinaconazole | SOLUTION;TOPICAL | 203567-001 | Jun 6, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Bausch | JUBLIA | efinaconazole | SOLUTION;TOPICAL | 203567-001 | Jun 6, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
Bausch | JUBLIA | efinaconazole | SOLUTION;TOPICAL | 203567-001 | Jun 6, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
Bausch | JUBLIA | efinaconazole | SOLUTION;TOPICAL | 203567-001 | Jun 6, 2014 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for EFINACONAZOLE
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 4414623 | Start Trial |
Hong Kong | 1146894 | Start Trial |
South Korea | 20100108555 | Start Trial |
China | 110433291 | Start Trial |
Japan | 6516759 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |